Document is current
Any future updates will be listed below
-
Authors
Kanamori, Masayuki https://orcid.org/0000-0002-3380-1192
Shibahara, Ichiyo
Shimoda, Yoshiteru
Akiyama, Yukinori
Beppu, Takaaki
Ohba, Shigeo
Enomoto, Toshiyuki
Ono, Takahiro
Mitobe, Yuta
Hanihara, Mitsuto
Mineharu, Yohei
Ishida, Joji
Asano, Kenichiro
Yoshida, Yasuyuki
Natsumeda, Manabu
Nomura, Sadahiro
Abe, Tatsuya
Yonezawa, Hajime
Katakura, Ryuichi
Shibui, Soichiro
Kuroiwa, Toshihiko
Suzuki, Hiroyoshi
Takei, Hidehiro
Matsushita, Haruo
Saito, Ryuta
Arakawa, Yoshiki
Sonoda, Yukihiko
Hirose, Yuichi
Kumabe, Toshihiro
Yamaguchi, Takuhiro
Endo, Hidenori
Tominaga, Teiji
-
Funding
Funding for this research was provided by:
Funds for this study were provided by Eisai, Co., Ltd.
- License Information
-
More Information
Article History
Received: 18 July 2024
Accepted: 22 October 2024
First Online: 11 November 2024
Declarations
:
: Masayuki Kanamori received a grant from Eisai Co. Ltd., and lecture honoraria from Eisai Co. Ltd. and Novocure Co. Ltd. Ichiyo Shibahara received lecture honoraria from Eisai Co. Ltd. and Novocure Co. Ltd. Yoshiteru Shimoda received a grant from Eisai Co. Ltd. Shigeo Ohba received lecture honoraria from Eisai Co. Ltd., and Novocure Co. Ltd. Toshiyuki Enomoto received lecture honoraria from Eisai Co. Ltd. and Novocure Co. Ltd. Mitsuto Hanihara received lecture honoraria from Eisai Co. Ltd. Yohei Mineharu received lecture honoraria from Eisai Co. Ltd., and Novocure Co. Ltd. Joji Ishida received lecture honoraria from Eisai Co. Ltd. Kenichiro Asano received lecture honoraria from Eisai Co. Ltd. Yasuyuki Yoshida received lecture honoraria from Eisai Co. Ltd. Manabu Natsumeda received lecture honoraria from Chugai Pharmaceutical Co., Ltd., Eisai Co. Ltd., and Novocure Co. Ltd., and support for travel for the conference from Eisai Co. Ltd., and Novocure Co. Ltd. Tatsuya Abe received grant from Chugai Pharmaceutical Co., Ltd. and lecture honoraria from Chugai Pharmaceutical Co., Ltd. and Novocure Co. Ltd. Hajime Yonezawa received lecture honoraria from Chugai Pharmaceutical Co., Ltd., Eisai Co. Ltd., and Novocure Co. Ltd. Soichiro Shibui received lecture honoraria from Chugai Pharmaceutical Co., Ltd. Ryuta Saito received lecture honoraria from Eisai Co. Ltd. and Novocure Co. Ltd. Yoshiki Arakawa received grant from Chugai Pharmaceutical Co., Ltd. and Eisai Co. Ltd. and lecture honoraria from Chugai Pharmaceutical Co., Ltd., Eisai Co. Ltd., Nippon Kayaku. and Novocure Co. Ltd. Yukihiko Sonoda received lecture honoraria from Chugai Pharmaceutical Co., Ltd., Eisai Co. Ltd., and Novocure Co. Ltd. Yuichi Hirose received a grant from Eisai Co. Ltd. and honoraria from Chugai Pharmaceutical Co., Ltd., Eisai Co. Ltd., and Novocure Co. Ltd. Toshihiro Kumabe received lecture honoraria and travel support from Chugai Pharmaceutical Co., Ltd., Eisai Co. Ltd., and Novocure Co. Ltd. Hidenori Endo received a grant from Eisai Co. Ltd. Teiji Tominaga received a grant from Eisai Co. Ltd. and honoraria from Chugai Pharmaceutical Co., Ltd., Eisai Co. Ltd., Nippon Kayaku, MSD, and Novocure Co. Ltd.Yukinori Akiyama, Takaaki Beppu, Yuta Mitobe, Takahiro Ono, Sadahiro Nomura, Ryuichi Katakura, Toshihiko Kuroiwa, Hiroyoshi Suzuki, Hidehiro Takei, and Haruo Matsushita have no conflict of interest.
: The study was conducted in accordance with the Declaration of Helsinki and the Japanese Ethical Guidelines for Medical and Health Research Involving Human Subjects. The Institutional Review Board of Tohoku University provided approval for the study (CRB2200003). The Institutional Review Board of Tohoku University Hospital provided approval for the molecular analysis (2015-2-126–1, 2023-1-971).
: Informed consent was obtained from all subjects involved in the study.
